3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
15
Leukemia, Myeloid, Acute
15
Myelodysplastic Syndromes
10
Recurrence
7
Ovarian Neoplasms
7
Multiple Myeloma
7
Pancreatic Neoplasms
6
Lymphoma
6
Lymphoma, Non-Hodgkin
5
Lymphoma, B-Cell
5
Colorectal Neoplasms
5
Burkitt Lymphoma
5
Stomach Neoplasms
4
Lymphoma, Large B-Cell, Diffuse
4
Leukemia, Myelomonocytic, Chronic
4
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
4
Hodgkin Disease
4
Hematologic Neoplasms
4
Sarcoma
3
Osteosarcoma
3
Lymphoma, Mantle-Cell
3
Lymphoma, Follicular
3
Leukemia, Biphenotypic, Acute
3
Leukemia, B-Cell
3
Leukemia
3
Colonic Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Urogenital Neoplasms
2
Triple Negative Breast Neoplasms
2
Thymoma
2
Interventions
Dexamethasone
2
Bortezomib
2
pomalidomide
1
isatuximab
1
fludarabine phosphate
1
elotuzumab
1
carfilzomib
1
belantamab mafodotin
1
Whole-Body Irradiation
1
Tacrolimus
1
Sirolimus
1
Peripheral Blood Stem Cell Transplantation
1
Patient Reported Outcome Measures
1
Mycophenolic Acid
1
Methotrexate
1
Melphalan
1
Lenalidomide
1
Etoposide
1
Cyclosporine
1
Cyclophosphamide
1
Busulfan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neoplasms, Plasma Cell
×
fludarabine
×
30 days
×
Clear all
No trials found.